Jason Flowerday--3DSignatures On The Cusp of Something Major #3411

For over a decade, Jason was groomed at two of the world’s largest pharmaceutical companies, Germany’s Bayer AG and US-based Johnson and Johnson before expanding his successful career into leading specialty pharmaceutical, biotech and device companies in their pursuit of growth and capital. Then he happened upon 3DSignatures, which he described as a diamond in the rough.

The quality of the research and technology coming out of the company was truly astounding. They may close to a number of major breakthroughs in the diagnosis and treatment of disease through the 3D Telomere Analysis. Without getting into a major dissertation on the subject, it enables scientists to analyze a particular portion of the chromosome, which Jason likens to the cap on a shoelace. The immediate applications are amazing, such as far more accurate prostate cancer tests, and personalized treatment plans for many different types of cancer. In fact 3DSignatures is working on 14 different diseases at this moment. Exciting times in biotech.